However, role of 2-DG in regulating pyroptosis, especially in breast cancer, where metabolic traits (e.g., elevated glycolysis) (13) and subtype heterogeneity (e.g., higher hexokinase-2 (HK2) expression in triple-negative breast cancer) (13) may alter responses, remains unclear. This evidence concerns the gene HK2 and breast cancer.